ArticleOncotarget2016

Parecoxib prevents complications in hepatocellular carcinoma patients receiving hepatic transarterial chemoembolization: a prospective score-matched cohort study.

Zhong-Guo Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.